Dr. Anton McCaffrey is the Senior Director of Emerging Science and Innovation at TriLink BioTechnologies and an adjunct Assistant Professor of Internal Medicine at the University of Iowa School of Medicine. Dr. McCaffrey has over 30 years of experience designing nucleic acid-based therapeutics for antisense, RNA interference, aptamer and genome editing applications. Dr. McCaffrey established the mRNA contract manufacturing program at TriLink BioTechnologies and led a research group that developed CleanCap® co-transcriptional capping reagents.  Dr. McCaffrey’s research interests include the role of the innate immune system in recognition of nucleic acid drugs.